Nagi Bioscience raises CHF 1.8 Million to accelerate its mission of setting a new standard for testing safety and efficacy of drugs and chemicals LAUSANNE, Switzerland – December 20, 2019 – Nagi Bioscience SA, a Swiss life-science-tech company developing a revolutionary technology for the in vitro testing of drugs and chemicals, announced today the closingRead more about Nagi Bioscience is proud to announce the closing of a CHF 1.8M Seed financing round[…]
According to the french web media Wydden, Nagi Bioscience is one of the 10 startups to follow in the BeautyTech industry! You can read the article published online by Wydden here. Good reading!
Nagi Bioscience is featured today in the online version of French Economic TV channel BFMTV. This article (in French) introduces the technology developed by our startup and its application for avoiding testing on animals for cosmetic, chemical industries and pharmas. You can read the article online here. Good reading!
Nagi Bioscience is featured today in the Economic Swiss newspaper Bilan. This article (in French) presents our startup and its device that avoids testing on animals for cosmetic, chemical industries and pharmas. You can read the article online here. Good reading!
We are glad to announce that Nagi is among the 66 high-impact startups that will join the final stage of the MassChallenge acceleration program. Our startup will benefit from world-class mentorship, programming, and resources during for improving our business case. The accelerator program will start in June and culminate on October 30th at the MassChallenge SwitzerlandRead more about Nagi Bioscience is part of the 2018 MassChallenge Accelerator Program[…]
Matteo and Laurent appeared respectively in two radio show broadcasted on the Swiss Radio RTS. They discuss the today’s problematic of animal testing and how the technology developed by Nagi Bioscience can bring an innovative solution to solve this issue. You can listen the live interview of Matteo and Laurent here and here (in French).
An interview with Matteo Cornaglia, our CEO, was published on te front page of the EPFL website, providing some insight about the how and why of the technology developed by Nagi Bioscience. You can see the video entitled “Tech-Transfer:worms in high-tech housing replace laboratory mice” here.
Every year, 10 Swiss-based entrepreneurs with international high potential are selected by venturelab for the Swiss National Startup Team. The members of this team, the venture leaders, win a week entrepreneurial and business development training based in the Boston, US. In the context of the program, he is going to pitch at the Startup ChampionsRead more about Matteo was selected for Venture Leaders Life Sciences 2018[…]
We are glad and very proud to be among the TOP50 start-up in which to invest in 2018 selected by the prestigious swiss economic newspaper Bilan. Every year, the magazine Bilan selects 50 of the most promising StartUps in Switzerland. A jury made up of innovation professionals selects Swiss nuggets, in fields as varied as fintech, biotech,Read more about Nagi Bioscience listed in Bilan’s top 50 Swiss start-up companies![…]
Nagi Bioscience is featured today in the Swiss newspaper Le Temps. This article (in French) discusses the current problematic of animal testing in the scientific research and highlight the solution developed by Nagi Bioscience. You can read the article online here or on the today’s paper version of the journal in the science section. Good reading!
In 2015, the project developed by Nagi Bioscience was the first recipient of the SGV 25th Fund. This fund was created by the SGV board to financially support projects related to the goals of the SGV, that are promotion of the Laboratory Animal Science and the Animal Welfare, and ethical considerations in animal experimentation. Read moreRead more about The platform developed by Nagi Bioscience is featured on the website of the Swiss Laboratory Animal Association (SGV)[…]
This prestigious prize is given annually by the “E. Naef Foundation for in vitro research” (FENRIV), established in 1998. The foundation assists researchers investigating scientific means for restricting the use of vivisection and generally promotes in vitro research. Our team has been awarded for its work on the development of a novel in vitro technologyRead more about Nagi Bioscience wins the Egon Naef Award 2017[…]
The EPFL website and the Swiss French Radio (RTS) have covered the publication of our last scientific paper. The article was published in Molecular Neurodegeneration and shows data about the in vivo analysis of the long-term dynamics of protein aggregation in C. elegans at unprecedented resolution.